免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth.
A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
TNF家族成员LIGHT(TNFSF14)与两种受体结合,即HVEM(TNFSFR14)和LTβR(TNFSFR3)。HVEM作为共刺激分子发挥作用,而LTβR参与淋巴结的发育以及慢性炎症部位异位三级淋巴结构的形成。将可溶性重组蛋白与IgG的Fc片段融合的经典方法产生了功能失活的Ig.小鼠(m)LIGHT蛋白。
然而,鉴于TNF家族成员以三聚体形式聚集受体这一事实,在mLIGHT的N端添加一个小型同源三聚化结构域(foldon)后,产生了Ig.Foldon-mLIGHT蛋白,该蛋白能够在基于细胞的报告基因生物试验中结合并激活HVEM和LTβR。在将B16.F10黑色素瘤细胞植入同基因受体的肿瘤模型中,转导膜结合型mLIGHT的细胞与模拟转导的细胞生长速度同样迅猛,但表达Ig.Foldon-mLIGHT的B16.F10细胞肿瘤生长延迟,并以树突状细胞和细胞毒性细胞的显著免疫浸润为特征。
本研究揭示了活性可溶性LIGHT作为单一药物在肿瘤部位招募细胞毒性细胞和树突状细胞以抑制肿瘤生长的潜力。这一效应可能通过免疫检查点阻断疗法进一步增强。关键信息:将可溶性重组蛋白与IgG的Fc片段融合的经典方法产生了功能失活的小鼠(m)LIGHT(TNFSF14)蛋白。在小鼠LIGHT的N端添加一个小型同源三聚化结构域(foldon)可产生正确折叠的生物活性小鼠LIGHT重组蛋白。肿瘤内组成性表达分泌型Ig-Foldon-LIGHT(而非膜型LIGHT)可延缓肿瘤生长。分泌LIGHT的肿瘤作为单一药物,通过招募和浸润细胞毒性细胞及树突状细胞促进有益的抗肿瘤反应。
The TNF family member LIGHT (TNFSF14) binds to two receptors, HVEM (TNFSFR14) and LTβR (TNFSFR3). HVEM functions as a costimulatory molecule, whereas LTβR is involved in the development of lymph nodes and ectopic tertiary lymphoid structures at chronic inflammation sites. The classical approach of fusing soluble recombinant proteins to the Fc fragment of IgG resulted in a functionally inactive Ig. mouse (m) LIGHT protein.
However, in line with the fact that TNF family members cluster receptors as trimers, addition of a small homotrimeric domain (foldon) N-terminal of mLIGHT produced an Ig. Foldon-mLIGHT protein able to bind and engage HVEM and LTβR in a cell-based reporter bioassay. In the tumor model of B16. F10 melanoma cells implanted into syngeneic recipients, cells transduced with membrane-bound mLIGHT grew as aggressively as mock-transduced cells, but growth of tumors of B16. F10 cells expressing Ig. Foldon-mLIGHT was delayed and characterized by significant immune infiltration of dendritic cells and cytotoxic cells. This work unveils the potential of active soluble LIGHT, as a single agent, to recruit cytotoxic cells and dendritic cells at the tumor site to inhibit tumor growth.
This effect may be further enhanced with immune checkpoint blockade therapies. KEY MESSAGES: The classical approach of fusing soluble recombinant proteins to the Fc fragment of IgG resulted in a functionally inactive Ig. mouse (m) LIGHT (TNFSF14) protein. The addition of a small homotrimeric domain (foldon) N-terminal of mouse LIGHT produces a proper folded bioactive mouse LIGHT recombinant protein.
Constitutive intratumor expression of secreted Ig-Foldon-LIGHT, but not membrane LIGHT, delays tumor growth. Tumors secreting LIGHT, as a single agent, promote beneficial anti-tumor responses through the recruitment and infiltration of cytotoxic cells and dendritic cells.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。